51.89
Celcuity Inc Aktie (CELC) Neueste Nachrichten
Earnings call transcript: Celcuity Q2 2025 earnings miss forecasts, stock reacts - Investing.com
Celcuity Inc. SEC 10-Q Report - TradingView
Celcuity Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Celcuity (CELC) Q2 2025 Earnings Call Transcript - Mitrade
Celcuity Q2 Adjusted Loss Widens - MarketScreener
Celcuity's Q1 2025 Earnings Miss: Weighing the Cost of Innovation in Biotech's High-Stakes Game - AInvest
Celcuity shares fall as second quarter loss exceeds estimates By Investing.com - Investing.com UK
Celcuity Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update - TradingView
RSI Suggests Rebound May Be Near in Celcuity Inc.July 2025 Recap & Daily Chart Pattern Signals - thegnnews.com
Celcuity : Corporate Presentation (Celcuity Investor Presentation V.6.16 Final) - MarketScreener
Diamedica Therapeutics shares rise 14.94% intraday after Celcuity's positive Phase 3 trial results. - AInvest
Celcuity announces $225M combined offerings; shares down - MSN
Celcuity CELC 2025Q2 Earnings Preview Upside Potential on Positive Clinical Trial Results - AInvest
Celcuity (CELC) Is Up 15.0% After Positive Phase 3 Results and $260 Million Capital Raise – Has The Bull Case Changed? - simplywall.st
Celcuity stock hits all-time high at 46.52 USD By Investing.com - Investing.com Nigeria
Celcuity stock hits all-time high at 46.52 USD - Investing.com India
Celcuity Inc expected to post a loss of 88 cents a shareEarnings Preview - TradingView
Celcuity Inc. Schedules Release of Second Quarter 2025 Financial Results and Webcast/Conference Call - The Manila Times
Celcuity Announces Q2 2025 Earnings Date: Biotech's Financial Results and Conference Call Details Revealed - Stock Titan
Celcuity Announces Q2 2025 Financial Results and Webcast/Conference Call on August 14, 2025. - AInvest
Celcuity Inc. shares rise 3.71% intraday as Novartis considers deal for biotech Avidity Biosciences. - AInvest
Celcuity Inc. shares fall 2.09% premarket after insider sells $4.82 million in stock. - AInvest
Celcuity’s Promising Clinical Trial Results and Strong Buy Recommendation by Andrew Berens - TipRanks
Celcuity Inc. Stock Analysis and ForecastCapitalize on market momentum for maximum gains - Jammu Links News
What drives Celcuity Inc. stock priceMaximize gains with expert analysis - Jammu Links News
What are analysts’ price targets for Celcuity Inc. in the next 12 monthsNavigate the market with precision tools - Jammu Links News
What are the technical indicators suggesting about Celcuity Inc.Unlock exclusive trading strategies - Jammu Links News
What is the risk reward ratio of investing in Celcuity Inc. stockPhenomenal returns - Jammu Links News
Should I hold or sell Celcuity Inc. stock in 2025Get expert analysis on top stock picks - Jammu Links News
How does Celcuity Inc. compare to its industry peersRapid return acceleration - Jammu Links News
Is it the right time to buy Celcuity Inc. stockBuild a winning investment portfolio - Jammu Links News
Why is Celcuity Inc. stock attracting strong analyst attentionAchieve rapid wealth accumulation through smart investing - Jammu Links News
What markets is Celcuity Inc. expanding into Is GSUN stock a good long term investment option - Jammu Links News
Celcuity Completes $201.25 Million Convertible Notes Issuance - MSN
What is the dividend policy of Celcuity Inc. stockExceptional risk-adjusted gains - Jammu Links News
What institutional investors are buying Celcuity Inc. stockSwing Trade Outlook For Every Investor - jammulinksnews.com
Celcuity Raises $248.7 Million Through Stock and Notes - The Globe and Mail
Celcuity Inc. stock trend outlook and recovery pathMarket Momentum Signal Generator Shows Trends - metal.it
Celcuity Inc. shares fall 1.57% after-hours as Novartis' Leqvio® receives FDA label update. - AInvest
Celcuity Inc's Recent Stock Offering: A Strategic Move in the Biotech Sector - AInvest
How strong is Celcuity Inc. company’s balance sheetSmart Portfolio Data Feed For 2025 - Jammu Links News
Celcuity prices $248.7M debt, stock offerings - MSN
Insiders Favor These 3 High Growth Companies - Yahoo Finance
Celcuity Inc. shares fall 1.24% after-hours following Novartis Canada's Scemblix approval expansion. - AInvest
Celcuity Surges 4.68% on $423.7M Capital Raise as $250M Volume Ranks 486th - AInvest
Dalvey David sells Celcuity (CELC) stock worth $4.8 million - Investing.com Australia
Dalvey David sells Celcuity (CELC) stock worth $4.8 million By Investing.com - Investing.com India
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):